摘要: Carbapenemase-producing organisms, or CPOs, are Gram-negative pathogens that produce a transmissible carbapenemase and typically resistant to most (sometimes all) antibiotics. We now face global CPO pandemic of high mortality. In this issue the Journal Clinical Microbiology, Karlowsky et al. (J Clin Microbiol 55:1638-1649, 2017, https://doi.org/10.1128/JCM.02316-16) report results an extensive surveillance study provide much-needed information enhances our understanding carbapenemase-producing Enterobacteriaceae (CPE) which will be valuable for development improved strategies CPE control therapy infections.
sci-hub.se 参考文章(17)
Simona Bratu, David Landman, Robin Haag, Rose Recco, Antonella Eramo, Maqsood Alam, John Quale, Rapid Spread of Carbapenem-Resistant Klebsiella pneumoniae in New York City Archives of Internal Medicine. ,vol. 165, pp. 1430- 1435 ,(2005) , 10.1001/ARCHINTE.165.12.1430
Zmira Samra, Orit Ofir, Yinon Lishtzinsky, Liora Madar-Shapiro, Jihad Bishara, Outbreak of carbapenem-resistant Klebsiella pneumoniae producing KPC-3 in a tertiary medical centre in Israel International Journal of Antimicrobial Agents. ,vol. 30, pp. 525- 529 ,(2007) , 10.1016/J.IJANTIMICAG.2007.07.024
Timothy R. Walsh, Emerging carbapenemases: a global perspective. International Journal of Antimicrobial Agents. ,vol. 36, pp. 8- 14 ,(2010) , 10.1016/S0924-8579(10)70004-2
M Watanabe, S Iyobe, M Inoue, S Mitsuhashi, Transferable imipenem resistance in Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy. ,vol. 35, pp. 147- 151 ,(1991) , 10.1128/AAC.35.1.147
L.S. Tzouvelekis, A. Markogiannakis, E. Piperaki, M. Souli, G.L. Daikos, Treating infections caused by carbapenemase-producing Enterobacteriaceae Clinical Microbiology and Infection. ,vol. 20, pp. 862- 872 ,(2014) , 10.1111/1469-0691.12697
T. R. Walsh, M. A. Toleman, The emergence of pan-resistant Gram-negative pathogens merits a rapid global political response Journal of Antimicrobial Chemotherapy. ,vol. 67, pp. 1- 3 ,(2012) , 10.1093/JAC/DKR378
David M Livermore, Jenny M Andrews, Peter M Hawkey, Pak-Leung Ho, Yoram Keness, Yohei Doi, David Paterson, Neil Woodford, Are susceptibility tests enough, or should laboratories still seek ESBLs and carbapenemases directly? Journal of Antimicrobial Chemotherapy. ,vol. 67, pp. 1569- 1577 ,(2012) , 10.1093/JAC/DKS088
Ioannis A. Bliziotis, George Samonis, Konstantinos Z. Vardakas, Stavroula Chrysanthopoulou, Matthew E. Falagas, Effect of Aminoglycoside and β-Lactam Combination Therapy versus β-Lactam Monotherapy on the Emergence of Antimicrobial Resistance: A Meta-analysis of Randomized, Controlled Trials Clinical Infectious Diseases. ,vol. 41, pp. 149- 158 ,(2005) , 10.1086/430912
Mical Paul, Adi Lador, Simona Grozinsky-Glasberg, Leonard Leibovici, Beta lactam antibiotic monotherapy versus beta lactam‐aminoglycoside antibiotic combination therapy for sepsis Cochrane Database of Systematic Reviews. ,vol. 2014, ,(2014) , 10.1002/14651858.CD003344.PUB3
Simona Bratu, Mohamad Mooty, Satyen Nichani, David Landman, Carl Gullans, Barbara Pettinato, Usha Karumudi, Pooja Tolaney, John Quale, Emergence of KPC-Possessing Klebsiella pneumoniae in Brooklyn, New York: Epidemiology and Recommendations for Detection Antimicrobial Agents and Chemotherapy. ,vol. 49, pp. 3018- 3020 ,(2005) , 10.1128/AAC.49.7.3018-3020.2005